Schedule 13G ownership disclosure
Compass Therapeutics Inc
Security class unavailable · CUSIP: 20454B104
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.5700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-24-001080
- Form type
- SC 13G
- Filer
- Compass Therapeutics, Inc.
- CIK
- CIK 1738021
- Filed
- Feb 09, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership